Abstract
Currently, clinical suspicion of histoplasmosis in AIDS patients is based on the evaluation of signs and symptoms presented by the patient, and on the use of nonspecific laboratory tests. The low specificity of the signs and symptoms seriously hinders their diagnosis. The choice of the initial antimycotic therapy is based on the clinical evaluation of the patients condition and this decision will directly affect mortality. It is therefore important to identify clinical and laboratory variables that could help to evaluate the degree of patient's involvement and in this way make a prompt and adequate choice of the induction therapy
| Translated title of the contribution | Histoplasmosis and AIDS: clinical and laboratory risk factors associated with the disease’s prognosis |
|---|---|
| Original language | Spanish (Colombia) |
| Pages (from-to) | 44-50 |
| Number of pages | 5 |
| Journal | Infectio |
| Volume | 16 |
| Issue number | s3 |
| State | Published - Dec 1 2012 |
